7.89

3.00% -0.28

Relay Therapeutics Inc (RLAY)

Overview News Price History Option Chain Financials Why RLAY Down? Discussions Forecast

Relay Therapeutics Inc stock is traded at $7.89, with a volume of 1.02M. It is down -3.00% in the last 24 hours and up +15.52% over the past month. Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Previous Close:

$8.17

Open:

$8.25

24h Volume:

1.02M

Relative Volume:

0.55

Market Cap:

$1.37B

Revenue:

$25.55M

Net Income/Loss:

$-341.97M

P/E Ratio:

-2.8179

EPS:

-2.8

Net Cash Flow:

$-304.44M

1W Performance:

+21.74%

1M Performance:

+15.52%

6M Performance:

+172.34%

1Y Performance:

+63.07%

1-Day Range:

$7.81

$8.36

1-Week Range:

$6.28

$8.36

52-Week Range:

$1.775

$8.36

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name

Relay Therapeutics Inc

Sector

Healthcare (1138)

Industry

Biotechnology (635)

Phone

617-370-8837

Address

60 HAMPSHIRE STREET, CAMBRIDGE

Employee

197

Twitter

Next Earnings Date

2025-02-21

Latest SEC Filings

RLAY's Discussions on Twitter

Compare RLAY with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RLAY Relay Therapeutics Inc	7.895	1.42B	25.55M	-341.97M	-304.44M	-2.80
VRTX Vertex Pharmaceuticals Inc	429.04	107.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	782.48	80.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	430.84	57.37B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	907.72	55.83B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	207.36	44.13B	447.02M	-1.18B	-906.14M	-6.1812

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-04-25	Resumed	Guggenheim	Buy
Apr-17-25	Initiated	Wells Fargo	Equal Weight
Sep-10-24	Resumed	Goldman	Buy
Sep-10-24	Upgrade	Jefferies	Hold → Buy
Sep-10-24	Downgrade	Oppenheimer	Outperform → Perform
May-10-24	Upgrade	Barclays	Equal Weight → Overweight
Apr-20-23	Upgrade	Jefferies	Underperform → Hold
Apr-19-23	Upgrade	Raymond James	Outperform → Strong Buy
Apr-13-23	Initiated	Raymond James	Outperform
Feb-03-23	Initiated	Oppenheimer	Outperform
Sep-30-22	Initiated	Barclays	Equal Weight
Sep-02-22	Initiated	Stifel	Buy
Jun-06-22	Initiated	Jefferies	Underperform
Feb-01-22	Initiated	Berenberg	Buy
Jul-21-21	Initiated	BofA Securities	Buy
Dec-15-20	Reiterated	H.C. Wainwright	Buy
Dec-08-20	Initiated	JMP Securities	Mkt Outperform
Nov-05-20	Initiated	H.C. Wainwright	Buy
Aug-10-20	Initiated	Cowen	Outperform
Aug-10-20	Initiated	Goldman	Buy
Aug-10-20	Initiated	Guggenheim	Buy
Aug-10-20	Initiated	JP Morgan	Neutral

View All

Relay Therapeutics Inc Stock (RLAY) Latest News

Nov 24, 2025

Relay Therapeutics stock hits 52-week high at $7.65 - Investing.com

Nov 24, 2025

Nov 20, 2025

Should I hold or sell Relay Therapeutics Inc. stock in 2025CEO Change & AI Based Buy and Sell Signals - newser.com

Nov 20, 2025

Key metrics from Relay Therapeutics Inc.’s quarterly data2025 Dividend Review & Technical Entry and Exit Alerts - newser.com

Nov 20, 2025

Is Relay Therapeutics Inc. stock a top momentum playJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com

Nov 20, 2025

Nov 19, 2025

Relay Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com

Nov 19, 2025

Nov 18, 2025